Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH Registry

Journal of the Neurological Sciences

Volumn 287, Issue 1-2, 2009, Pages 45-51

  Uchiyama, Shinichiro ^a   Goto, Shinya ^b   Matsumoto, Masayasu ^c   Nagai, Ryozo ^d   Origasa, Hideki ^e   Yamazaki, Tsutomu ^f   Shigematsu, Hiroshi ^g   Shimada, Kazuyuki ^h   Yamada, Nobuhiro ⁱ   Bhatt, Deepak L ^j   Steg, P Gabriel ^k   Ikeda, Yasuo ^l  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g TOKYO MEDICAL UNIVERSITY   (Japan)

^h JICHI MEDICAL UNIVERSITY   (Japan)

ⁱ UNIVERSITY OF TSUKUBA   (Japan)

^j VA BOSTON HEALTHCARE SYSTEM   (United States)

^k INSERM   (France)

^l KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Atherothrombosis; Cerebrovascular disease; Coronary artery disease; Epidemiology; Japan; Peripheral artery disease

Indexed keywords

AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; FEMALE; HEART INFARCTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RECURRENCE RISK; REGISTER; RISK ASSESSMENT; STROKE;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CAROTID STENOSIS; CAUSALITY; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; TIME FACTORS;

EID: 70350619615     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.09.011     Document Type: Article

References (24)

1. Jemal A., Ward E., Hao Y., and Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 294 (2005) 1255-1259
2. Japanese Statistics and Information Department. Abridged life tables for Japan (2005) accessed on Feb 26, 2007
3. Yamazaki T., Goto S., Shigematsu H., Shimada K., Uchiyama S., Nagai R., et al. Prevalence, awareness, and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Results from domestic baseline data of the REduction of Atherothrombosis for Continued Health (REACH) registry. Circ J 71 (2007) 995-1003
4. Ohman E.M., Bhatt D.L., Steg P.G., Goto S., Hirsch A.T., Liau C.S., et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J 151 (2006) 786
5. Chang I.M., Gelman R., and Pagano M. Corrected group prognostic curves and summary statistics. J Chronic Dis 35 (1982) 669-674
6. Steg P.G., Bhatt D.L., Wilson P.W., D'Agostino R.S., Ohman E.M., Röther J., et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297 (2007) 1197-1206
7. Bhatt D.L., Steg P.G., Ohman E.M., Hirsch A.T., Ikeda Y., Mas J.L., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 (2006) 180-189
8. Goto S., Bhatt D.L., Rother J., Alberts M., Hill M.D., Ikeda Y., et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 156 (2008) 855-863
9. Liu L., Ikeda K., and Yamori Y. Changes in stroke mortality rates for 1950 to 1997: a great slowdown of decline trend in Japan. Stroke 32 (2001) 1745-1749
10. Kobayashi S. Stroke Databank (2005), Nakayama Shoten K.K, Tokyo
11. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
12. Hankey G.J., Jamrozik K., Broadhurst R.J., Forbes S., Burvill P.W., Anderson C.S., et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 31 (2000) 2080-2086
13. Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke 31 (2000) 817-821
14. Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Kaste M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attach in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
15. Toyoda K., Yasaka M., Iwade K., Nagata K., Koretsune Y., Sakamoto T., et al. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective multicenter observational study. Stroke 39 (2008) 1740-1745
16. Fukuuchi Y., Tohgi H., Okudera T., Ikeda Y., Miyanaga Y., Uchiyama S., et al. A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction. Cerebrovasc Dis 25 (2008) 40-49
17. Liao J.K. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?. Circulation 115 (2007) 1615-1621
18. Plosker G.L., and Lyseng-Williamson K.A. Clopidogrel: a review of its use in the prevention of thrombosis. Drugs 67 (2007) 613-646
19. Bhatt D.L., Kapadia S.R., Yadav J.S., and Topol E.J. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases. Cerebrovasc Dis 10 Suppl. 5 (2000) 34-40
20. Missault L., Krygier C., Lukito G., and Mary-Rabine L. Occurrence of peripheral arterial disease in a Belgian cohort of patients with cardiovascular history of atherothrombosis. Acta Chir Belg 107 (2007) 508-514
21. Cheng S.W., Wu L.L., lau H., Ting A.C., and Wong J. Prevalence of significant carotid stenosis in Chinese patients with peripheral and coronary artery disease. Aust N Z Surg 69 (1999) 44-47
22. Leng G.C., Fowkes F.G., Lee A.J., Dunbar J., Housley E., and Ruckley C.V. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 313 (1996) 1440-1444
23. Hiatt W.R. Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy. J Intern Med 251 (2002) 193-206
24. Ferrières J., Cambou J.P., Gayet J.L., Herrmann M.A., and Leizorovicz A. Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting. Int J Cardiol 112 (2006) 302-307